Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Russkamp

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|May 12, 2017
Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergySimon Blank, Stefanie Etzold, Ulf Darsow, et al.
Plos One|June 2, 2017
Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthmaAntonio Aguilar-Pimentel, Anke Graessel, Francesca Alessandrini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2019
RelB Deficiency in Dendritic Cells Protects from Autoimmune Inflammation Due to Spontaneous Accumulation of Tissue T Regulatory CellsNico Andreas, Maria Potthast, Anna-Lena Geiselhöringer, et al.
Pharmaceutics|July 27, 2022
Thermosensitive PLGA-PEG-PLGA Hydrogel as Depot Matrix for Allergen-Specific ImmunotherapySonja Heine, Antonio Aguilar-Pimentel, Dennis Russkamp, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 30, 2018
Characterization of the honeybee venom proteins C1q-like protein and PVF1 and their allergenic potentialDennis Russkamp, Matthias Van Vaerenbergh, Stefanie Etzold, et al.
Allergy|July 21, 2021
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergyAlexander Heldner, Francesca Alessandrini, Dennis Russkamp, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|May 12, 2017
Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergySimon Blank, Stefanie Etzold, Ulf Darsow, et al.
Plos One|June 2, 2017
Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthmaAntonio Aguilar-Pimentel, Anke Graessel, Francesca Alessandrini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2019
RelB Deficiency in Dendritic Cells Protects from Autoimmune Inflammation Due to Spontaneous Accumulation of Tissue T Regulatory CellsNico Andreas, Maria Potthast, Anna-Lena Geiselhöringer, et al.
Pharmaceutics|July 27, 2022
Thermosensitive PLGA-PEG-PLGA Hydrogel as Depot Matrix for Allergen-Specific ImmunotherapySonja Heine, Antonio Aguilar-Pimentel, Dennis Russkamp, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 30, 2018
Characterization of the honeybee venom proteins C1q-like protein and PVF1 and their allergenic potentialDennis Russkamp, Matthias Van Vaerenbergh, Stefanie Etzold, et al.
Allergy|July 21, 2021
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergyAlexander Heldner, Francesca Alessandrini, Dennis Russkamp, et al.
Pageof 1